CLINICAL TRIALS PROFILE FOR ISOSORBIDE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for isosorbide
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Indication | NCT01478022 ↗ | To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 | Completed | Parent Project, Italy | Phase 1 | 2011-10-01 | This study will evaluate the pharmacokinetics plasma profile of 3 treatments: ISO 20, IBU 200 and IBU and ISO combinations (200 +20) given in single dose. This study is being conducted to support the submission for new indication in treatment of the combinations of Isosorbide Dinitrate and Ibuprofen as a treatment for Duchenne muscular dystrophy. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for isosorbide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000478 ↗ | Asymptomatic Cardiac Ischemia Pilot (ACIP) Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1990-11-01 | To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia. |
| NCT00143195 ↗ | Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina | Completed | Pfizer | Phase 4 | 2001-04-01 | The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocardial ischemia |
| NCT00143195 ↗ | Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 | 2001-04-01 | The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocardial ischemia |
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | Diabetes Australia | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | Hoffmann-La Roche | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| NCT00168519 ↗ | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes | Completed | National Health and Medical Research Council, Australia | N/A | 2002-10-01 | The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for isosorbide
Condition Name
Clinical Trial Locations for isosorbide
Trials by Country
Clinical Trial Progress for isosorbide
Clinical Trial Phase
Clinical Trial Sponsors for isosorbide
Sponsor Name
